The genome-wide mutational consequences of DNA hypomethylation
暂无分享,去创建一个
E. Cuppen | S. Boymans | A. van Hoeck | J. de Ridder | N. Besselink | E. Kuijk | Carlo Vermeulen | Janneke Keijer | C. Vermeulen | Nicolle J. M. Besselink
[1] S. Nik-Zainal,et al. Substitution mutational signatures in whole-genome–sequenced cancers in the UK population , 2022, Science.
[2] E. Cuppen,et al. Precancerous liver diseases do not cause increased mutagenesis in liver stem cells , 2021, Communications Biology.
[3] E. Cuppen,et al. MutationalPatterns: the one stop shop for the analysis of mutational processes , 2021, bioRxiv.
[4] A. Straight,et al. AlphaHOR-RES: a method for enriching centromeric DNA v1 , 2021 .
[5] V. Barra,et al. Losing DNA methylation at repetitive elements and breaking bad , 2021, Epigenetics & chromatin.
[6] Aaron M. Streets,et al. The complete sequence of a human genome , 2021, bioRxiv.
[7] Jose Espejo Valle-Inclan,et al. GRIDSS2: comprehensive characterisation of somatic structural variation using single breakend variants and structural variant phasing , 2021, Genome Biology.
[8] David T. W. Jones,et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition , 2020, Nature Genetics.
[9] Nuno A. Fonseca,et al. Patterns of somatic structural variation in human cancer genomes , 2020, Nature.
[10] Runan Yao,et al. ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..
[11] Huimin Shen,et al. Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis , 2019, Journal of Ovarian Research.
[12] A. Aguilera,et al. R Loops: From Physiological to Pathological Roles , 2019, Cell.
[13] David A Eccles. Creating Differential Transcript Expression Results with DESeq2 v1 , 2019, protocols.io.
[14] Jose Espejo Valle-Inclan,et al. GRIDSS, PURPLE, LINX: Unscrambling the tumor genome via integrated analysis of structural variation and copy number , 2019, bioRxiv.
[15] Nicholas A. Rossi,et al. Inference of CRISPR Edits from Sanger Trace Data , 2019, bioRxiv.
[16] S. Malek,et al. The Genomic Landscape of Centromeres in Cancers , 2019, Scientific Reports.
[17] A. Scelfo,et al. Keeping the Centromere under Control: A Promising Role for DNA Methylation , 2019, Cells.
[18] A. Meissner,et al. Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors , 2019, Nature Communications.
[19] E. Cuppen,et al. 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer , 2019, Nature Communications.
[20] J. S. Pedersen,et al. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer , 2019, Genome research.
[21] E. Cuppen,et al. Early divergence of mutational processes in human fetal tissues , 2019, Science Advances.
[22] Thomas Lengauer,et al. RnBeads 2.0: comprehensive analysis of DNA methylation data , 2019, Genome Biology.
[23] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[24] E. Cuppen,et al. The mutational impact of culturing human pluripotent and adult stem cells , 2018, Nature Communications.
[25] S. Sleijfer,et al. Pan-cancer whole-genome analyses of metastatic solid tumours , 2018, bioRxiv.
[26] Edwin Cuppen,et al. MutationalPatterns: comprehensive genome-wide analysis of mutational processes , 2016, Genome Medicine.
[27] S. Nik-Zainal,et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer , 2017, Science.
[28] Hemali P. Phatnani,et al. Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes , 2017, Stem cell reports.
[29] M. Goodell,et al. DNMT3A in Leukemia. , 2017, Cold Spring Harbor perspectives in medicine.
[30] Xing-Ming Zhao,et al. OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines , 2016, Nucleic Acids Res..
[31] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[32] Max A. Horlbeck,et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.
[33] J. Shay,et al. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies , 2016, Genome Medicine.
[34] Victor Guryev,et al. Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies , 2016, Genome Biology.
[35] K. Kaestner,et al. DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation , 2016, Cancer Prevention Research.
[36] A. Di Leonardo,et al. DNA demethylation caused by 5-Aza-2′-deoxycytidine induces mitotic alterations and aneuploidy , 2016, Oncotarget.
[37] D. Durocher,et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.
[38] Matthew Meyerson,et al. CHROMOTHRIPSIS FROM DNA DAMAGE IN MICRONUCLEI , 2015, Nature.
[39] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[40] Jérôme Déjardin,et al. Constitutive heterochromatin formation and transcription in mammals , 2014, Epigenetics & Chromatin.
[41] Winston Timp,et al. Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors , 2014, Genome Medicine.
[42] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[43] B. Bernstein,et al. Epigenetic Reprogramming in Cancer , 2013, Science.
[44] J. Wong,et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9 , 2013, Nature Communications.
[45] Howard Cedar,et al. DNA methylation dynamics in health and disease , 2013, Nature Structural &Molecular Biology.
[46] W. Kaelin,et al. Use and Abuse of RNAi to Study Mammalian Gene Function , 2012, Science.
[47] G. Vance,et al. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability , 2012, Oncogene.
[48] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[49] J. Vijg,et al. 5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1 , 2012, Oncogene.
[50] P. Laird,et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.
[51] Bypass of cell cycle arrest induced by transient DNMT1 post-transcriptional silencing triggers aneuploidy in human cells , 2012, Cell Division.
[52] C. Cole,et al. COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.
[53] M. Esteller,et al. DNMT3B gene amplification predicts resistance to DNA demethylating drugs , 2011, Genes, chromosomes & cancer.
[54] W. Reik,et al. Epigenetic Reprogramming in Plant and Animal Development , 2010, Science.
[55] A. Hagemeijer,et al. Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.
[56] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[57] D. Schübeler,et al. Genetics and epigenetics: stability and plasticity during cellular differentiation. , 2009, Trends in genetics : TIG.
[58] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[59] E. Li,et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells , 2007, Nature Genetics.
[60] C. Allis,et al. Epigenetics: A Landscape Takes Shape , 2007, Cell.
[61] Jing Chen,et al. Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues , 2007, International Journal of Colorectal Disease.
[62] M. Fraga,et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.
[63] S. Matsui,et al. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.
[64] N. Eberhardt,et al. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. , 2005, Gynecologic oncology.
[65] Li Yang,et al. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. , 2004, World journal of gastroenterology.
[66] C. Shen,et al. DNA methyltransferase Dnmt1 and mismatch repair , 2004, Oncogene.
[67] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[68] R. Jaenisch,et al. Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.
[69] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[70] W. Lau,et al. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. , 2001, The American journal of pathology.
[71] M. Ehrlich,et al. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.
[72] Rudolf Jaenisch,et al. DNA hypomethylation leads to elevated mutation rates , 1998, Nature.
[73] D. Santi,et al. Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.